SYNCROSOME - Cardiovascular Preclinical expert Revenue

Research Services • 163 avenue de Luminy, Campus Luminy – Luminy Entreprises CP 908, France • 1-10 Employees

SYNCROSOME - Cardiovascular Preclinical expert revenue & valuation

Annual revenue	$769,995
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues	$2,500,000
Total funding	No funding

Key Contacts at SYNCROSOME - Cardiovascular Preclinical expert

Nicolas Violle

Ceo - Président

Sandra Robelet

Study Director

Company overview

Headquarters	163 avenue de Luminy, Campus Luminy – Luminy Entreprises CP 908, MARSEILLE cedex 09, 13288, FR
Phone number	+33495053180
Websites	eatp-lab.com syncrosome.com
NAICS	5417
SIC	873
Keywords	Preclinical Cro, Heart Failure, Drug Testing, In Depth Efficacy Characterization Cro, In Vivo Drug Efficacy Studies, Hfpef, Cardiorespiratory, Animal Model, Cns Preclinical Cro, Cardiovascular Preclinical Cro, Myocardial Ischemia, Pulmonary Arterial Hypertension Pah, Respiratory Preclinical Cro, Hfref, Acute Myocardial Ischaemia
Founded	2000
Employees	1-10
Socials

SYNCROSOME - Cardiovascular Preclinical expert Email Formats

SYNCROSOME - Cardiovascular Preclinical expert uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@syncrosome.com), used 75% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@syncrosome.com	75%
{first initial}.{last name}	j.doe@syncrosome.com	25%

About SYNCROSOME - Cardiovascular Preclinical expert

At a glimpse SYNCROSOME is the cardiology lab of ETAP-Lab, French preclinical CRO dedicated to efficacy studies for pharmaceutical & biotech companies. Our range of services SYNCROSOME is a dedicated lab for cardiovascular & respiratory diseases models like HFrEF, HFpEF, acute myocardial ischemia and arterial/pulmonary arterial hypertension… Models in cardiometabolic disorders are also available. Check out our cardiovascular models in our website! Working with us • Personalized & expert advisory • Tailor-made & flexible study designs • Constant innovation & validated methods • Technical expertise & production facilities • Advanced technological capabilities • Robustness, Translational-approach, & Expertise Zoom on ETAP-Lab The company is a French preclinical CRO with over 30 years' expertise in derisking research & advancing drug development for pharmaceutical and biotech companies. Our expertise covers dermatological, cardiological, neurovascular and neurological diseases thanks to our dedicated research labs.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

Director

Manager

Employees by Department

SYNCROSOME - Cardiovascular Preclinical expert has 6 employees across 4 departments.

Departments

Number of employees

Funding Data

SYNCROSOME - Cardiovascular Preclinical expert has never raised funding before.

Frequently asked questions

SYNCROSOME - Cardiovascular Preclinical expert is located in 163 avenue de Luminy, Campus Luminy – Luminy Entreprises CP 908, FR.

You can reach SYNCROSOME - Cardiovascular Preclinical expert at +33495053180.

SYNCROSOME - Cardiovascular Preclinical expert generates an estimated annual revenue of $769,995. This revenue figure reflects the company's market position and business performance in its industry.

SYNCROSOME - Cardiovascular Preclinical expert has an estimated valuation of $2,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

SYNCROSOME - Cardiovascular Preclinical expert was founded in 2000, making it 26 years old. The company has established itself as a significant player in its industry over this time.

SYNCROSOME - Cardiovascular Preclinical expert has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at SYNCROSOME - Cardiovascular Preclinical expert

Nicolas Violle

Ceo - Président

Sandra Robelet

Study Director

4.8

40,000 users